Vision Point Advisory Group, LLC Annexon, Inc. Transaction History
Vision Point Advisory Group, LLC
- $473 Million
- Q3 2025
A detailed history of Vision Point Advisory Group, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 15,000 shares of ANNX stock, worth $47,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$47,250% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ANNX
# of Institutions
139Shares Held
96.4MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...